The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-phenoxyphenyl)-7-(pyridin-4-yl)-2,3-dihydrobenzo[f][1,4]oxazepine-4(5H)-carboxamide ID: ALA4756931
PubChem CID: 162656305
Max Phase: Preclinical
Molecular Formula: C27H23N3O3
Molecular Weight: 437.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1cccc(Oc2ccccc2)c1)N1CCOc2ccc(-c3ccncc3)cc2C1
Standard InChI: InChI=1S/C27H23N3O3/c31-27(29-23-5-4-8-25(18-23)33-24-6-2-1-3-7-24)30-15-16-32-26-10-9-21(17-22(26)19-30)20-11-13-28-14-12-20/h1-14,17-18H,15-16,19H2,(H,29,31)
Standard InChI Key: WYIJQVYRDZGFGZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
17.0688 -21.6019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0677 -22.4214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7757 -22.8304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7739 -21.1930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3615 -22.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6538 -22.4189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9463 -22.8262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9452 -23.6443 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6576 -24.0533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3622 -23.6436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4873 -22.4185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4825 -21.5983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1235 -21.0773 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1373 -22.9282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9280 -21.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9403 -22.7369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.2893 -21.9893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4567 -23.3703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1663 -24.1342 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2634 -23.2399 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7797 -23.8733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4866 -24.6357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0022 -25.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8098 -25.1386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0992 -24.3699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5818 -23.7401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9055 -24.2366 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.4240 -24.8682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1348 -25.6319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6526 -26.2631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4598 -26.1301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7465 -25.3603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2269 -24.7324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 11 2 0
12 4 2 0
4 1 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
2 5 1 0
11 12 1 0
12 13 1 0
11 14 1 0
13 15 1 0
14 16 1 0
15 17 1 0
16 17 1 0
16 18 1 0
18 19 2 0
18 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
25 27 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 437.50Molecular Weight (Monoisotopic): 437.1739AlogP: 5.97#Rotatable Bonds: 4Polar Surface Area: 63.69Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.94CX Basic pKa: 5.16CX LogP: 4.65CX LogD: 4.65Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.43Np Likeness Score: -1.43
References 1. Wilson JE,Kurukulasuriya R,Sinz C,Lombardo M,Bender K,Parker D,Sherer EC,Costa M,Dingley K,Li X,Mitelman S,Tong S,Bugianesi R,Ehrhardt A,Priest B,Ratliff K,Ujjainwalla F,Nargund R,Hagmann WK,Edmondson S. (2016) Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine GPR142 agonists for the treatment of diabetes., 26 (12.0): [PMID:27240550 ] [10.1016/j.bmcl.2016.04.018 ]